Kamiya Kazutaka, Takahashi Masahide, Igarashi Akihito, Shoji Nobuyuki
Visual Physiology, School of Allied Health Sciences, Kitasato University, Kanagawa, Japan.
Department of Ophthalmology, Kitasato University, Kanagawa, Japan.
Cornea. 2019 Jan;38(1):89-92. doi: 10.1097/ICO.0000000000001761.
To compare the rate of central island (CI) and visual acuity after phototherapeutic keratectomy (PTK) with and without the CI program.
This retrospective study comprised 147 eyes of 89 consecutive patients (mean age ± SD, 71.1 ± 9.6 years) undergoing PTK with and without the anti-CI program [photorefractive keratectomy (PRK) mode and PTK mode] using the VISX Star S4 excimer laser system (Johnson & Johnson Vision, Santa Ana, US) for treatment of band keratopathy (BK) or granular corneal dystrophy (GCD). The rate of CI formation, defined as a steepening area of 3 D, 1.5 mm in diameter, on each corneal videokeratographer (ATLAS 9000; Carl Zeiss Meditec, Jena), and best spectacle-corrected visual acuity (BSCVA) were assessed 3 months after PTK.
We found CI formation in 17 eyes (22%) in the PRK mode group and 45 eyes (73%) in the PTK mode group at 3 months postoperatively (P < 0.001, χ test). Postoperative logarithm of the minimal angle of resolution BSCVA was 0.10 ± 0.14 in the PRK group and 0.15 ± 0.13 in the PTK group (P = 0.019, Student t test). The rate of CI was 13 eyes (33%) with BK and 6 eyes (15%) with GCD in the PRK mode group and 25 eyes (83%) with BK and 20 eyes (71%) with GCD in the PTK mode group.
The use of the anti-CI program for PTK significantly decreases the rate of CI formation and significantly improves BSCVA in post-PTK eyes, suggesting its viability for treatment of BK and GCD in clinical setting.
比较采用和不采用中央岛(CI)程序进行光治疗性角膜切削术(PTK)后的中央岛发生率和视力。
这项回顾性研究纳入了89例连续患者的147只眼(平均年龄±标准差,71.1±9.6岁),这些患者使用VISX Star S4准分子激光系统(美国圣安娜的强生视力健公司)采用和不采用抗CI程序[屈光性角膜切削术(PRK)模式和PTK模式]进行PTK,以治疗带状角膜病变(BK)或颗粒状角膜营养不良(GCD)。在PTK术后3个月,评估每个角膜地形图仪(ATLAS 9000;德国耶拿的卡尔蔡司医疗技术公司)上定义为直径1.5毫米、陡峭度为3D的CI形成率,以及最佳眼镜矫正视力(BSCVA)。
我们发现,术后3个月时,PRK模式组有17只眼(22%)形成CI,PTK模式组有45只眼(73%)形成CI(P<0.001,χ检验)。PRK组术后最小分辨角对数BSCVA为0.10±0.14,PTK组为0.15±0.13(P=0.019,学生t检验)。PRK模式组中BK患者有13只眼(33%)形成CI,GCD患者有6只眼(15%)形成CI;PTK模式组中BK患者有25只眼(83%)形成CI,GCD患者有20只眼(71%)形成CI。
PTK采用抗CI程序可显著降低CI形成率,并显著提高PTK术后眼的BSCVA,表明其在临床环境中治疗BK和GCD的可行性。